235 related articles for article (PubMed ID: 37534019)
1. A Framework to Overcome Challenges in the Management of Infections in Patients with Systemic Lupus Erythematosus.
Rao M; Mikdashi J
Open Access Rheumatol; 2023; 15():125-137. PubMed ID: 37534019
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus and infections.
Singh BK; Singh S
Reumatismo; 2020 Nov; 72(3):154-169. PubMed ID: 33213128
[TBL] [Abstract][Full Text] [Related]
3. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
4. Management of infection in systemic lupus erythematosus.
Sciascia S; Cuadrado MJ; Karim MY
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):377-89. PubMed ID: 24238694
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever.
Beça S; Rodríguez-Pintó I; Alba MA; Cervera R; Espinosa G
Autoimmun Rev; 2015 Jul; 14(7):586-93. PubMed ID: 25703012
[TBL] [Abstract][Full Text] [Related]
6. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
8. Measuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus.
Tang KT; Hsieh TY; Chen YM; Hsieh CW; Chen YH; Chen DY
Lupus; 2014 Aug; 23(9):926-34. PubMed ID: 24704776
[TBL] [Abstract][Full Text] [Related]
9. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.
Jung JY; Suh CH
Korean J Intern Med; 2017 May; 32(3):429-438. PubMed ID: 28490724
[TBL] [Abstract][Full Text] [Related]
10. Update οn the diagnosis and management of systemic lupus erythematosus.
Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
[TBL] [Abstract][Full Text] [Related]
11. Latent Class Analysis Identifies Distinct Phenotypes of Systemic Lupus Erythematosus Predictive of Flares after mRNA COVID-19 Vaccination: Results from the Coronavirus National Vaccine Registry for ImmuNe Diseases SINGapore (CONVIN-SING).
Sim TM; Lahiri M; Ma M; Cheung PP; Mak A; Fong W; Angkodjojo S; Xu C; Kong KO; Arkachaisri T; Phang KF; Tan TC; Yap QV; Chan YH; Sriranganathan M; Chuah TY; Roslan NE; Poh YJ; Law A; Santosa A; Tay SH
Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38250842
[TBL] [Abstract][Full Text] [Related]
12. How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
Thanou A; Chakravarty E; James JA; Merrill JT
Rheumatology (Oxford); 2014 Dec; 53(12):2175-81. PubMed ID: 24729400
[TBL] [Abstract][Full Text] [Related]
13. Reduced Rate of Disease Flares in Japanese Patients with Systemic Lupus Erythematosus: An Altered Balance between the Use of Glucocorticoids and Immunosuppressants in Recent Decades.
Imaizumi C; Ogura T; Inoue Y; Takakura Y; Katagiri T; Takenaka S; Ito H; Mizushina K; Hirata A; Kameda H
Intern Med; 2022; 61(21):3189-3196. PubMed ID: 36328585
[TBL] [Abstract][Full Text] [Related]
14. The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Piga M; Arnaud L
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33440874
[TBL] [Abstract][Full Text] [Related]
15. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus.
Katz P; Wan GJ; Daly P; Topf L; Connolly-Strong E; Bostic R; Reed ML
Qual Life Res; 2020 Dec; 29(12):3251-3261. PubMed ID: 32683643
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing infections vs flares in patients with systemic lupus erythematosus.
Ospina FE; Echeverri A; Zambrano D; Suso JP; Martínez-Blanco J; Cañas CA; Tobón GJ
Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i46-i54. PubMed ID: 27744359
[TBL] [Abstract][Full Text] [Related]
18. Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Mok CC; Chan KL; Tse SM
Vaccine; 2022 Sep; 40(41):5959-5964. PubMed ID: 36085256
[TBL] [Abstract][Full Text] [Related]
19. Delta neutrophil index as a marker for differential diagnosis between flare and infection in febrile systemic lupus erythematosus patients.
Pyo JY; Park JS; Park YB; Lee SK; Ha YJ; Lee SW
Lupus; 2013 Oct; 22(11):1102-9. PubMed ID: 23934401
[TBL] [Abstract][Full Text] [Related]
20. Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.
Torres-Ruiz J; Barrera-Vargas A; Ortiz-Hernández R; Alcocer-Varela J; Ponce-de-León A; Gómez-Martín D
Lupus; 2018 Feb; 27(2):312-318. PubMed ID: 28699377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
